SNAI1 and posterior cortical atrophy: These results indicate that miR-30e-5p acts as an inhibitor of PCa carcinogenesis and progression by targeting SNAI1 and mediating EMT, suggesting that miR-30e-5p and SNAI1 may be used as novel therapeutic targets for PCa treatment.